Currently, the drug is only approved by the Food and Drug Administration (FDA) for the long-term treatment of obesity (with or without Type 2 diabetes) in children who are at least 12 years old.
More than 30,000 people were admitted to hospital with obesity in Hampshire last year, new figures show. It comes as the number of admissions for obesity across England rose. Campaign group Action on ...